Regenerative Medicine bill introduced in US
This article was originally published in RAJ Devices
Legislation has been introduced in the US House of Representatives that would establish grant programmes to accelerate the availability of regenerative medicine therapies and research tools, fund regulatory research at the US Food and Drug Administration and create a multiagency co-ordinating council within the Department of Health and Human Services1.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.